Cargando…
Fc Engineering for Developing Therapeutic Bispecific Antibodies and Novel Scaffolds
Therapeutic monoclonal antibodies have become molecules of choice to treat autoimmune disorders, inflammatory diseases, and cancer. Moreover, bispecific/multispecific antibodies that target more than one antigen or epitope on a target cell or recruit effector cells (T cell, natural killer cell, or m...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5266686/ https://www.ncbi.nlm.nih.gov/pubmed/28184223 http://dx.doi.org/10.3389/fimmu.2017.00038 |